This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
The following Wikipedia contributor has declared a personal or professional connection to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.
This edit request by an editor with a conflict of interest has now been answered.
Information to be added or removed: Remove: Commercialization Section
Explanation of issue: Information is out of date (2016 reference)
References supporting change: URL sited (footnote 4) cannot be accessed and is significantly out of date
DaveGancarz (talk) 03:13, 3 December 2020 (UTC)[reply]
This edit request by an editor with a conflict of interest has now been answered.
Information to be added or removed: REMOVE under Section: Regulatory Information, the subsection: Phase III Clinical Trials (entire subsection to be removed)
Explanation of issue: Information is significantly out of date - reference url is from 2016 and can no longer be accessed via the page
References supporting change: Referenced source is both out of date and no longer accessible on the page (footnote 4)
DaveGancarz (talk) 03:16, 3 December 2020 (UTC)[reply]
There appears to be some issues with this page, including COI/NPOV issues. For example, even though this is an article about a medical drug (and so I assume is under the more stringent sourcing requirements for medical articles), many of the references don't appear reliable at all. Refs #3, #5, #6, and #8 (as of the current article) are press releases from the drug's manufacturer; ref #4 is a Google docs that doesn't seem to load; ref #7 doesn't mention the drug at all; ref #9 appears to be to an NHS intranet that you need a login for. I don't think this would even be good enough for a non-medical article - that's why I added {{More medical citations needed}}. In terms of my COI concerns: there seem to be some previous editors of the article who may work for Summit Therapeutics (the manufacturer), and aren't following the {{request edit}} process, as has been done in the sections above. Therefore, this may not follow the NPOV policy completely - eg: in the lead where it says that the drug's "mechanism of action "remains to be fully determined", it is then followed by a quote from the manufacturer saying that they believe it works. Seagull123 Φ 17:22, 3 December 2020 (UTC)[reply]
I posted a notice on Wikipedia talk:WikiProject Medicine because of the request edit template. I agree that this article needs a clean up because of WP:PROMO and WP:PUFF, and I haven't even looked at the sources yet. I hope someone from WP Med will give some guidance on how to fix up this article and if the request edit should be included. Z1720 (talk) 22:18, 3 December 2020 (UTC)[reply]
I've done some cleanup and added information from a nice review article (Cho 2019). More work can be done, but this is still an investigational agent. — soupvector (talk) 01:23, 4 December 2020 (UTC)[reply]
This edit request by an editor with a conflict of interest has now been answered.
Information to be added or removed: In the last sentence of the article, edit to the following: As of 2020, two Phase II trials have been completed.[4] Two Phase III trials are currently in process by Summit Therapeutics.[1]
Explanation of issue: Current text states indicates information from 2019 (referring to planned phase III; these trials are in process, as described by the NIH's website (url included below).
References supporting change: https://clinicaltrials.gov/ct2/show/NCT03595566DaveGancarz (talk) 03:13, 4 December 2020 (UTC)[reply]
